Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PONTIROLI AE")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

HISTAMINE STIMULATES PROLACTIN RELEASE IN NORMAL MEN.PONTIROLI AE; POZZA G.1978; ACTA ENDOCRINOL.; DANEM.; DA. 1978; VOL. 88; NO 1; PP. 23-28; BIBL. 33 REF.Article

TREATMENT OF HYPERPROLACTINAEMIA WITH METERGOLINE FOR PERIODS UP TO 5 YEARS: CLINICAL AND BIOLOGICAL TOLERABILITYFALSETTI L; VOLTOLINI AM; SCHIMBERNI M et al.1983; CURRENT MEDICAL RESEARCH AND OPINION; ISSN 0300-7995; GBR; DA. 1983; VOL. 8; NO 5; PP. 327-332; BIBL. 14 REF.Article

A STUDY OF PROLACTIN, FOLLICLE-STIMULATING HORMONE, AND LUTEINIZING HORMONE IN PUERPERIUM: SPONTANEOUS VARIATIONS AND THE EFFECT OF METERGOLINEFALSETTI L; VOLTOLINI AM; POLLINI C et al.1982; FERTIL. STERIL.; ISSN 0015-0282; USA; DA. 1982; VOL. 37; NO 3; PP. 397-401; BIBL. 20 REF.Article

GLUCAGON (IRG) AND INSULIN (IRI) RESPONSE TO ARGININE (ARG) IN THE RAT PANCREAS IN VITRO: EFFECT OF HISTAMINE (HA) AND SEROTONIN (5HT)PONTIROLI AE; MICOSSI P; FOA PP et al.1980; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1980; VOL. 12; NO 12; PP. 703-704; BIBL. 10 REF.Article

GROWTH HORMONE RESPONSE TO ARGININE IN NORMAL SUBJECTS AND IN PATIENTS WITH CHEMICAL DIABETES AND EFFECT OF CLOFIBRATE AND OF METERGOLINE.PONTIROLI AE; VIBERTI G; POZZA G et al.1977; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1977; VOL. 155; NO 2; PP. 160-163; BIBL. 32 REF.Article

METERGOLINE VERSUS BROMOCRIPTINE IN THE PREVENTION OF PUERPERAL LACTATION. A DOUBLE-BLIND CLINICAL TRIALSCAPIN F; BUONACCORSI S; TRONCONI G et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 2; PP. 181-183; BIBL. 19 REF.Article

BENSERAZIDE AND NOMIFENSINE IN THE DIAGNOSIS OF PROLACTIN-SECRETING PITUITARY ADENEMASPONTIROLI AE; LODA G; ROGGIA A et al.1982; ACTA ENDOCRINOLOGICA (KOBENHAVN); ISSN 0001-5598; DNK; DA. 1982; VOL. 101; NO 2; PP. 171-179; BIBL. 22 REF.Article

PARENTERAL ADMINISTRATION OF KETOPROFEN IN OSTEOARTHRITIS. A DOUBLE-BLIND TRIAL VERSUS THE N-METHYL-D-GLUCAMINE SALT OF INDOMETHACINFRANCHI R; LIVERTA C; POLLINI C et al.1979; SCAND. J. RHEUMATOL., SUPPL.; SWE; DA. 1979; NO 26; 7 P.; BIBL. 15 REF.Serial Issue

EFFECTS OF NALOXONE ON PROLACTIN, LUTEINIZING HORMONE, AND CORTISOL RESPONSES TO SURGICAL STRESS IN HUMANSPONTIROLI AE; BAIO G; STELLA L et al.1982; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1982; VOL. 55; NO 2; PP. 373-380; BIBL. 19 REF.Article

EFFECT OF METERGOLINE, A SPECIFIC SEROTONIN ANTAGONIST, ON HUMAN GROWTH HORMONE RESPONSE TO ARGININE AND L-DOPAPONTIROLI AE; VIBERTI GC; TOGNETTI A et al.1976; HORMONE METABOL. RES.; GERM.; DA. 1976; VOL. 8; NO 2; PP. 106-108; BIBL. 22 REF.Article

FAILURE OF AMANTADINE TO MODIFY SERUM GROWTH HORMONE AND INSULIN LEVELS = INCAPACITE DE L'AMANTADINE A MODIFIER LES TENEURS DU SERUM EN HORMONE DE CROISSANCE ET EN INSULINECAVAGNINI F; PONTIROLI AE; RAGGI U et al.1973; EXPERIENTIA; SUISSE; DA. 1973; VOL. 29; NO 5; PP. 573; ABS. ITAL.; BIBL. 16REF.Serial Issue

EFFECT OF METERGOLINE, A POWERFUL AND LONG-ACTING ANTISEROTONINERGIC AGENT, ON INSULIN SECRETION IN NORMAL SUBJECTS AND IN PATIENTS WITH CHEMICAL DIABETES. = ACTION DE LA METERGOLINE, UN ANTISEROTONINERGIQUE PUISSANT ET L'ACTION PROLONGEE SUR LA SECRETION D'INSULINE CHEZ LE SUJET NORMAL ET DANS LE DIABETE CHIMIQUEPONTIROLI AE; VIBERTI GC; TOGNETTI A et al.1975; DIABETOLOGIA; ALLEM.; DA. 1975; VOL. 11; NO 2; PP. 165-167; BIBL. 19 REF.Article

LONG-TERM CONTINUOUS INTRAPERITONEAL INSULIN TREATMENT IN BRITTLE DIABETESPOZZA G; SPOTTI D; MICOSSI P et al.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6361; PP. 255-256; BIBL. 3 REF.Article

CERULETIDE AND IRI AND BLOOD GLUCOSE LEVELS IN NORMAL SUBJECTS AND IN DIABETICS: A CONTROLLED STUDYPONTIROLI AE; ALBERETTO M; VEGETO G et al.1982; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1982; VOL. 14; NO 6; PP. 329-330; BIBL. 7 REF.Article

DIFFERENT EFFECTS OF HISTAMINERGIC H1 AND H2 ANTAGONISTS ON BASAL AND STIMULATED INSULIN AND GLUCAGON RELEASE IN HUMANSPONTIROLI AE; PETRELLI PL; VICARI A et al.1982; HORM. METAB. RES.; ISSN 0018-5043; USA; DA. 1982; VOL. 14; NO 9; PP. 496-497; BIBL. 10 REF.Article

INSULIN GIVEN INTRANASALLY INDUCES HYPOGLYCAEMIA IN NORMAL AND DIABETIC SUBJECTSPONTIROLI AE; ALBERETTO M; SECCHI A et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6312; PP. 303-306; BIBL. 9 REF.Article

SINGLE NIGHTLY ADMINISTRATION OF KETOPROFEN (ORUDIS) AND INDOMETHACIN SUPPOSITORIES IN THE MANAGEMENT OF OSTEOARTHRITIS: A DOUBLE-BLIND TRIAL.FAVA G; GALLI L; POLLINI C et al.1977; J. INTERNATION. MED. RES.; G.B.; DA. 1977; VOL. 5; NO 5; PP. 301-307; BIBL. 22 REF.Article

CIMETIDINE AND L-DOPA IN THE CONTROL OF PROLACTIN SECRETION IN MANPONTIROLI AE; PELLICCIOTTA G; ALBERETTO M et al.1979; HORMONE METABOL. RES.; DEU; DA. 1979; VOL. 11; NO 3; PP. 257-258; BIBL. 8 REF.Article

STUDY ON THE REPRODUCIBILITY OF HUMAN PROLACTIN RESPONSE TO SULPIRIDE, BENSERAZIDE, INSULIN HYPOGLYCAEMIA AND ARGININE INFUSIONPONTIROLI AE; GALA RR; PELLICCIOTTA G et al.1979; ACTA ENDOCRINOL.; DNK; DA. 1979; VOL. 91; NO 3; PP. 410-420; BIBL. 24 REF.Article

INTERACTION OF DOPAMINERGIC AND ANTISEROTONINERGIC DRUGS IN THE CONTROL OF PROLACTIN AND LH RELEASE IN NORMAL WOMENPONTIROLI AE; ALBERETTO M; PELLICCIOTTA G et al.1980; ACTA ENDOCRINOL.; DNK; DA. 1980; VOL. 93; NO 3; PP. 271-276; BIBL. 2 P.Article

A METHOD FOR EARLY DETECTION OF GRAFT FAILURE IN PANCREAS TRANSPLANTATIONSECCHI A; PONTIROLI AE; TRAEGER J et al.1983; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1983; VOL. 35; NO 4; PP. 344-348; BIBL. 13 REF.Article

A DOUBLE-BLIND CROSS-OVER EVALUATION OF KETOPROFEN (ORUDIS) AND IBUPROFEN IN THE MANAGEMENT OF RHEUMATOID ARTHRITISMONTRONE F; FUMAGALLI M; PELLEGRINI P et al.1979; RHEUMATOL. AND REHABILIT.; GBR; DA. 1979; VOL. 18; NO 2; PP. 114-118; BIBL. 16 REF.Article

EFFECT OF L-DOPA ADMINISTRATION ON GROWTH HORMONE SECRETION IN NORMAL SUBJECTS AND PARKINSONIAN PATIENTS = EFFET DE L'ADMINISTRATION DE LA L-DOPA SUR LA SECRETION D'HORMONE SOMATOTROPE CHEZ DES SUJETS NORMAUX ET DES PARKINSONIENSCAVAGNINI F; PERACCHI M; SCOTTI G et al.1972; J. ENDOCRINOL.; G.B.; DA. 1972; VOL. 54; NO 3; PP. 425-433; BIBL. 46REF.Article

BENSERAZIDE, A STIMULATOR OF PROLACTIN RELEASE: A NEW TEST IN THE DIAGNOSIS OF PITUITARY PROLACTIN SECRETIN TUMOURSPONTIROLI AE; FALSETTI L; VOLTOLINI AM et al.1981; ACTA ENDOCRINOL. (KBH.); ISSN 0001-5598; DNK; DA. 1981; VOL. 98; NO 3; PP. 326-332; BIBL. 19 REF.Article

METERGOLINE IN THE MANAGEMENT OF HYPERPROLACTINEMIC AMENORRHEA AND ANOVULATIONFALSETTI L; VOLTOLINI AM; CROSIGNANI PG et al.1982; GYNECOL. OBSTET. INVEST.; ISSN 0378-7346; CHE; DA. 1982; VOL. 13; NO 2; PP. 108-116; BIBL. 20 REF.Article

  • Page / 2